-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
2021 Shandong Province's Second Batch of Technological Innovation Projects -- (Ruxolitinib Hydrochloride, Propafenone Hydrochloride)
Keyword:
Category:
Product Description
- 产品描述
-
- Commodity name: 2021 Shandong Province's Second Batch of Technological Innovation Projects -- (Ruxolitinib Hydrochloride, Propafenone Hydrochloride)
If you are interested in this product, please fill in the following information and submit it to us, and we will arrange for an expert to contact you as soon as possible!
Related Products
Related Products
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline